Coinbase
COIN
Ecopetrol
EC
Oracle
ORCL
4
Meta Platforms
META
5
Vale SA
VALE
US Stock MarketDetailed Quotes
MRKR Marker Therapeutics
- 1.135
- -0.005-0.40%
Trading May 13 13:04 ET
12.16MMarket Cap-0.95P/E (TTM)
1.180High1.090Low18.19KVolume1.180Open1.140Pre Close20.42KTurnover0.28%Turnover RatioLossP/E (Static)10.71MShares5.99052wk High0.66P/B7.41MFloat Cap0.95052wk Low--Dividend TTM6.53MShs Float2447.998Historical High--Div YieldTTM7.89%Amplitude0.670Historical Low1.122Avg Price1Lot Size
Marker Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -5.50%-10.91M | -104.07%-4.7M | 238.09%1.2M | 12.37%-3.57M | -23.85%-3.84M | 51.93%-10.34M | 43.84%-2.3M | 83.47%-867.18K | -6,643.44%-4.07M | 74.66%-3.1M |
| Net income from continuing operations | 23.60%-10.73M | -40.05%-3.84M | 22.59%-2.31M | 46.51%-2.19M | 43.36%-2.39M | 28.97%-14.05M | 9.96%-2.74M | 47.93%-2.98M | -274.22%-4.1M | 57.37%-4.22M |
| Change In working capital | -114.93%-424.87K | -413.60%-916.06K | 77.98%3.45M | -1,071.48%-1.44M | -426.46%-1.52M | 159.76%2.85M | 120.24%292.11K | 1,202.48%1.94M | -90.96%147.97K | 109.76%466.74K |
| -Change in receivables | -195.98%-1.32M | -69.64%-1.6M | 4.99%1.75M | -289.64%-638.69K | -358.10%-823.65K | 157.22%1.37M | -31.00%-944.5K | 257.85%1.66M | 153.85%336.79K | 16,481.83%319.12K |
| -Change in prepaid assets | -41.42%504.41K | -27.48%682.56K | 37.96%218.12K | -70.16%-467.39K | 95.10%71.12K | 726.82%861.11K | 205.23%941.23K | 50.53%158.11K | 54.04%-274.68K | -87.36%36.45K |
| -Change in payables and accrued expense | -36.26%389.61K | -99.09%3.68K | 13,051.90%1.49M | -486.01%-331.42K | -793.69%-771.18K | 146.32%611.26K | 139.10%402.91K | -98.53%11.32K | -97.03%85.86K | 102.81%111.17K |
| Cash from discontinued investing activities | 0 | 0 | 0 | 0 | 0 | -11.73%-6.1M | 97.14%-62.94K | 89.15%-260.28K | -2.99M | -2.79M |
| Operating cash flow | 33.64%-10.91M | -98.65%-4.7M | 206.21%1.2M | 49.44%-3.57M | 34.83%-3.84M | 39.05%-16.44M | 62.45%-2.37M | 85.25%-1.13M | -787.95%-7.06M | 51.84%-5.89M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | 477.42%18.66M | --0 | --0 | 928.54%18.78M | 95.41%-112.61K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,256.54%14.99M | 289,985.90%14.9M | -99.65%1.7K | 5,960.60%44.61K | -92.08%49.1K | 446.74%1.11M | -96.29%5.14K | 479.27K | -98.84%736 | 619.97K |
| Net common stock issuance | 1,371.37%14.93M | --14.89M | --0 | --36.9K | --0 | 401.97%1.01M | --0 | --394.67K | --0 | --619.97K |
| Proceeds from stock option exercised by employees | -31.30%62.16K | -28.76%3.66K | -97.99%1.7K | 946.74%7.7K | --49.1K | --90.48K | --5.14K | --84.61K | --736 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,256.54%14.99M | 289,985.90%14.9M | -99.65%1.7K | 5,960.60%44.61K | -92.08%49.1K | 446.74%1.11M | -96.29%5.14K | --479.27K | -98.84%736 | --619.97K |
| Net cash flow | ||||||||||
| Beginning cash position | 28.26%15.11M | -48.50%9M | -56.96%7.8M | 76.89%11.32M | 28.26%15.11M | -72.91%11.78M | -3.33%17.47M | -29.82%18.12M | -77.79%6.4M | -72.91%11.78M |
| Current changes in cash | 22.58%4.08M | 531.45%10.19M | 285.01%1.2M | -130.06%-3.52M | 29.60%-3.79M | 110.50%3.33M | 62.47%-2.36M | 91.63%-648.19K | 491.04%11.72M | 63.34%-5.38M |
| End cash Position | 27.01%19.19M | 27.01%19.19M | -48.50%9M | -56.96%7.8M | 76.89%11.32M | 28.26%15.11M | 28.26%15.11M | -3.33%17.47M | -29.82%18.12M | -77.79%6.4M |
| Free cash flow | 33.64%-10.91M | -98.65%-4.7M | 206.21%1.2M | 49.44%-3.57M | 34.83%-3.84M | 39.05%-16.44M | 62.45%-2.37M | 85.25%-1.13M | -525.74%-7.06M | 59.88%-5.89M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025